MGD

(redirected from Meibomian Gland Dysfunction)
Also found in: Medical.
AcronymDefinition
MGDMouse Genome Database
MGDMiller Genuine Draft (Beer)
MGDMillions of Gallons per Day
MGDMultimedia Graphic Design (various schools)
MGDMeibomian Gland Dysfunction (eye)
MGDMachine-Generated Data
MGDMultiple Gland Disease
MGDMagnetogasdynamic(s)
MGDMOS Gate Driver
MGDMilitary Geographic Documentation
MGDMicrostrip Gap Discontinuity
MGDModified Galois field Design
MGDMeguma Gold Deposits
References in periodicals archive ?
Grafton Optical has launched a new rental scheme for its E-Eye technology, which is designed to specifically treat dry eye as a result of Meibomian gland dysfunction (MGD).
Tenders are invited for Supply of Thermal Pulsation System for Treatment of Meibomian Gland Dysfunction
Of these, there was systemic drug use in 5, diabetes mellitus in two and five, pterygium in 3 and meibomian gland dysfunction in 1).
10,11,12) Androgen deficiency may lead to meibomian gland dysfunction and evaporative dry eye syndrome.
Conclusions: IVCM application provides a strong support to differentiate dry eye patients with different symptoms: meibomian gland dysfunction (MGD) plays a pivotal role in dry eye aggravation, and using IVCM to observe MG fibrosis, changes in size and density of MG as well as status of inflammation cells can help not only correctly diagnose the type and severity of dry eye, but also possibly prognosticate in routine eye examination in the occurrence of MGD.
Specifically designed for treating dry eye diseases caused by Meibomian gland dysfunction (MGD), the technology behind the E-Eye offers long term relief for patients.
Effect of oral linoleic and gamma linolenic acid on meibomian gland dysfunction.
Dry eye, blepharitis and meibomian gland dysfunction (MGD) happen to be "the big three" in terms of eye discomfort or eye problems, notes Clayton Reeves, commercial sales coordinator at OCuSOFT.
Lab tests show that the company's proprietary formulation of hypochlorous acid is effective in solution both at killing microbes and at neutralizing the bacterial enzymes and toxins that contribute to common eye conditions like blepharitis, meibomian gland dysfunction and associated dry eye.
3] Various risk factors for dry eye alluded to in literature include air pollution; cigarette smoking; low humidity; high temperature; sunlight exposure; drugs race; ethnicity; female sex; ocular conditions such as blepharitis, meibomian gland dysfunction, and conjunctival disease; presence of systemic conditions including connective tissue diseases, osteoporosis, diabetes mellitus, human immunodeficiency virus (HIV), gout, and thyroid disorders; systemic cancer chemotherapy and medications such as isotretinoin, antidepressants, anxiolytics, b-blockers, diuretics; after corneal, retinal, or ocular oncologic surgery.
which makes treatments for meibomian gland dysfunction (MGD), has appointed a new president and CEO.
Twenty patients with blepharitis due to meibomian gland dysfunction were randomly assigned to receive 5% N-acetylcysteine (NAC) eyedrops or a topical steroid-antibiotic combination (0.